Resistancepatterns | Name of drugs | Total patients N = 64 n (%) | Relapse N = 44 n (%) | TF N = 5 n (%) | F/U N = 6 n (%) | RAD N = 4 n (%) | Chronic N = 2 n (%) | Others N = 3 n (%) |
Susceptible to all four drugs | SM + INH + RIF + EMB | 36 (56.2) | 24 (54.5) | 3 (60) | 4 (66.7) | 1 (25) | 1 (50) | 3 (100) |
Mono drug resistance |
SM INH RIF EMB | 12 (18.7) 2 (3.1) 7 (10.9) 2 (3.1) 1 (1.6) | 8 (18.2) 0 (0.0) 6 (13.6) 1 (2.3) 1 (2.3) | 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) | 2 (33.4) 1 (16.7) 0 (0.0) 1 (16.7) 0 (0.0) | 2(50) 1(25) 1(25) 0 (0.0) 0 (0.0) | 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) | 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) |
Double drug resistance |
INH + RIF RIF + SM SM + EMB EMB + INH RIF + EMB SM + INH | 11 (17.2) 7 (10.9) 0 (0.0) 1 (1.6) 0 (0.0) 0 (0.0) 3 (4.7) | 8 (18.2) 6 (13.6) 0 (0.0) 1 (2.3) 0 (0.0) 0 (0.0) 1 (2.3) | 2 (40) 1 (20) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (20) | 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) | 1 (25) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (25) | 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) | 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) |